RVPH: Full Year 2023 Results

18h ago, source: Zacks Small Cap Research on MSN

RVPH READ THE FULL RVPH RESEARCH REPORT 2023 Financial and Operational Results On April 15th, 2024, Reviva Pharmaceutical ...

RVPH Reviva Pharmaceuticals Holdings, Inc.

9d ago, source: Seeking Alpha

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs ...

Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights

10d ago, source:

RECOVER-1 Phase 3 global trial successfully met all primary and secondary endpoints with statistically significant reductions ...

Reviva Pharmaceuticals Holdings Inc. (RVPH) Stock: Analyzing the Market Value

6d ago, source: newsheater

The 36-month beta value for RVPH is at 0.04. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.” The public float ...

Analysts Are Bullish on Top Healthcare Stocks: Reviva Pharmaceuticals Holdings (RVPH), Roivant Sciences (ROIV)

3d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Reviva Pharmaceuticals Holdings (RVPH – ...

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting

29d ago, source: Business Insider

CUPERTINO, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

21d ago, source: Yahoo Finance

April 15, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a late-stage pharmaceutical company developing therapies CUPERTINO, Calif., March 28, 2024 (GLOBE NEWSWIRE ...

Reviva Pharmaceuticals Holdings, Inc.

5mon ago, source: CNN

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory ...

Reviva Pharmaceuticals Holdings Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Reviva Pharmaceuticals Holdings Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

7d ago, source: Investing

NEW YORK - Reviva Pharmaceuticals Holdings, Inc. has entered into an agreement for an at-the-market offering, announcing the sale of shares and warrants with a projected closing ...